Concepedia

J Schulz

JS

3

Publications

606

Citations

3

H-Index

2002

Active since

Affiliations

Universität Hamburg(Current)

J Schulz is an author at Universität Hamburg specializing in medicine, cancer research, and translational medicine.

Top concepts

Publications per year

2002–2004

3

Publications

3

A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer

Simon R. Bramhall, J Schulz, John Nemunaitis et al. · British Journal of Cancer · 2002 · 559 citations · Full text

Bevacizumab (a monoclonal antibody to vascular endothelial growth factor) to prolong progression-free survival in first-line colorectal cancer (CRC) in subjects who are not suitable candidates for first-line CPT-11

Fairooz F. Kabbinavar, J Schulz, Michael McCleod et al. · Journal of Clinical Oncology · 2004 · 34 citations

, , +19

Gemcitabine and mitomycin C in advanced pancreatic cancer: a single-institution experience

Gert Tuinmann, Susanna Hegewisch‐Becker, R. Zschaber et al. · Anti-Cancer Drugs · 2004 · 13 citations

Rows per page

1–3 of 3